{"id":"W1968524867","doi":"10.1053/j.seminoncol.2010.06.001","title":"Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer","year":2010,"lang":"en","type":"review","venue":"Seminars in Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Zoledronic acid; Renal cell carcinoma; Cancer; Placebo; Internal medicine; Oncology; Bladder cancer; Bone disease; Urology; Kidney cancer; Surgery; Pathology; Osteoporosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002192827,0.0004277281,0.001684569,0.001193248,0.0001100453,0.0003800339,0.0005038088,0.0004521848,0.00167064],"category_scores_gemma":[0.0006239488,0.0001732507,0.0006898607,0.00165117,0.0001643133,0.0003047132,0.000229897,0.0004335571,0.0003262839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003949617,"about_ca_system_score_gemma":0.000833378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002777898,"about_ca_topic_score_gemma":0.009402742,"domain_scores_codex":[0.9998798,0.00002058771,0.00003121348,0.00001973357,0.00003838016,0.00001018831],"domain_scores_gemma":[0.9998142,0.00009466003,0.00005674667,0.000002890961,0.00002227799,0.000009218201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005511205,0.00005311259,0.002403024,0.0483494,0.001144035,0.0004582796,0.00004517057,0.0003863736,0.001241753,0.0004019406,0.01521762,0.9297482],"study_design_scores_gemma":[0.001634146,0.001559433,0.0594951,0.03144621,0.01534229,0.01595885,0.0003364179,0.0007459457,0.00226075,0.001400266,0.8696949,0.0001255754],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005079225,0.9989545,0.00003453947,0.00008632426,0.00005407746,0.000003035272,0.00003442182,0.000003236093,0.0003219765],"genre_scores_gemma":[0.00572317,0.9935882,0.00009816192,0.0002007777,0.00008282775,0.000005691297,0.00006280684,7.134922e-7,0.0002376426],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002777898,"threshold_uncertainty_score":0.00558883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04216482054983896,"score_gpt":0.3604882786700274,"score_spread":0.3183234581201885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}